The effect of treatment by L-carnitine for infertile men on semen parameters
Article Sidebar
Main Article Content
Abstract
L-Carnitine (LC) is highly concentrated in the epididymis and plays a crucial role in sperm metabolism and maturation.
They are related to sperm motility and have antioxidant properties. The objective of this review is to summarize the multiple roles played by LC in male reproduction, and to highlight their limitations as well as their benefits in the treatment of male infertility. A variety of studies support the conclusion that LC at total daily amounts of at least 500mg per day can significantly improve both sperm concentration and total sperm counts among men with astheno – or oligoasthenozoospermia. Although many clinical trials have demonstrated the beneficial effects of LC in selected cases of male infertility.
Additional, a well – designed study is necessary to further validate the use of carnitines in the treatment of patients with male infertility, specifically in men with poor semen quality .
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Alla Hamadaa, Sandro C. Esteves, Mark Nizza, Ashok Agarwal., (2012). Unexplained Male infertility : Diagnosis and Manegment. Int Braz J Urol.; 38: 576- 94.
[2] Alla Hamadaa ,Sandro, C.; Estevesb and Ashok Agrwal, (2011). Unexplained male infertility: Potential causes and management. Human Andrology.:1:2-16.
whose time is now. Systems Biology in Reproductive Medicine.; (52)4: 269-274.
[4] Cathy K. Naughton, Ajay K. Nangia and Ashok Agarwal, (2007). Varicoceles in male infertility . Human Reproduction Updates. 2001; 17(5): 473-481. (IVSL.org). Chamley LW.
[5] Boivin, J,; Bunting, L,; Collins, JA, Nygren KG (2007). International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod.; 22(6):1506–12.
[6] Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA,(2012). National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med.; 9(12):e1001356.
[7] Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Mathers CD, Stevens GA, (2013). Trends in primary and secondary infertility prevalence since 1990: a systematic analysis of demographic and reproductive health surveys. The Lancet.; 381(S90).
[8] McLachlan RI, de Kretser DM, (2001). Male infertility: The case for continued research. MJA.; 174: 116–117.
[9] Murray Mt.; and Pizzorno J, (1998). Encyclopedia of natural medicine. 2ndEd. Joseph and Michael. California.:575-583.
[10] Tindall VR, (1997). Principles of gynaecology. 5thEd. Butterworth Heinemann. London.:578-585.
[11] Johnson MH.; and Everitt BJ,(1988). Essential reproduction. 3rdEd. Blackwell scientific publications. Oxford.:42, 356-358.
[12] Hart DM.; Norman J,; Callander R,: and Ramsden I, (2000). Gynaecology illustrated. 5thEd. Churchill livingstone. Edinburgh.: 391-397.
[13] WHO, (2000) Manual for the Standadised Investigation and Diagnosis the Infertile Couple. Cambridge: Cambridge University Press.
[14] Kollettis PN, (2003). Evaluation of the subfertile man. Am Fam Physician;67: 2165-73.
[15] Jeulin C, Lewin ML,(1996). Role of free L-carnitine and acetyl L- carnitine in postgonadal maturation of mammalian spermatozoa. Hum Reprod Update; 2 : 87-102.
[16] Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT and Vogelsong KM. (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16: 231–245.
[17] Nagler HM and Grotas A. (2009). Varicocele. In: Lipshultz LI, Howards SS and Niederberger CS (eds). Infertility in the male. 4 th ed. Cambridge: Cambridge University Press, 331–361.
[18] Nallella KP, Allamaneni SS, Pasqualotto FF, Sharma RK, Thomas AJ, Jr. and Agarwal A. (2004). Relationship of interleukin-6 with semen
characteristics and oxidative stress in patients with varicocele. Urology 64: 1010–1013.
[19] Moretti E, Cosci I, Spreafico A, Serchi T, Cuppone AM and Collodel G. (2009). Semen characteristics and inflammatory mediators in infertile men with different clinical diagnoses. Int J Androl 32: 637–646.
[20] Gilbert BR, Witkin SS and Goldstein M. (1989). Correlation of sperm-bound immunoglobulins with impaired semen analysis in infertile men with varicoceles. Fertil Sterile 52: 469–473.
[21] Naughton CK, Nangia AK and Agarwal A. (2001). Pathophysiology of varicoceles in male infertility. Hum Reprod Update 7: 473–481.
[22] Koide SS, Wang L and Kamada M. (2000). Antisperm antibodies associated with infertility: Properties and encoding genes of target antigens. Proc Soc Exp Biol Med 224: 123–132. [23] Choudhury SR, Knapp LA 2001. Human reproductive failure II: Immunogenetic and interacting factors. Hum Reprod Update, 7: 135-160.
[24] Chamley LW, Clarke GN (2007). Antisperm Antibodies and Conception. Seminars in Immunopathol. 29(2):169-184.
[25] NG Chiu Ming, Blackman MR, Wang C, (2004), swerdloff s. The role of carnitine in the male reproductive system. Ann N Y AcadSci; 1033:177-88.
[26] Sigman M, Stacy GRN, Janice C, Jon LP, (2006). Carnitine for the treatment of idiopathic asthenospermia: a randomized, double blind placebo controlled trial. Fertil: Steril; 85: 1409-14.
[27] Rebouche C, (1988). Carnitine metabolism and human nutrition , J Appli Nutr; 40:99-111.
[28] Vas FM, Wanders RJA, (2002). Carnitine biosynthesis in mammals J; 361:417-29.
[29] Casillas ER,(1973). Accumulation of carnitine by bovine spermatozoa during maturation in the epididymis. J BiolChem; 248: 8227-32.
[30] Matalliotakis I, Youmantaki Y, Evageliou A, Matalliotakis G, Goumenou A, Koumantakis E, (2000). L- carnitine level in the seminal plasma of fertile and infertile men: Correlation with sperm quality. Int J Fertil;45: 236-240.
[31] Muroya, K., Sasagawa, I., Suzuki, Y. (2010). Hypospadias and theandrogen receptor gene: Mutation screening and CAG repeat length analysis. Molecular Human Reproduction. 7(5):409-413.
[32] Marbut MM. Ihsan, M. Ezedeen, F. Abdul-Ghani, M. (2006). Elemental Analysis of Human Semen. Tikrit Med. J.; 12(1):47-52.
[33] Sharma RK, Agarwal A. (1996). Role of reactive oxygen species in male infertility. (Review). Urology. 48:835 -850.
[34] Aitken. RJ.; (1999). The Amoroso lecture. The human spermatozoon—a cell in crisis? J Reprod Ferti. 115:1 -7.
[35] Schiff J.D., Ramirez M.L., and Bar-Chama N, (2007). Medical and surgical management of male infertility. Endocrinol Metab Clin N Am;; 36: 313-331.1093-9.
[36] Peivandi S.,Karimpour A., and Moslemizadeh N, (2010). Effects of L-carnitine on infertile men's spermogram: a randomized clinical trial. J Reprod Fertil;; 10(4): 41-44.
[37] Kerner J., and Hoppel C,(1998). Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr;; 18: 179-206. 38-Agarwal A, and Saleh RA, (2005). Role of oxidants in male infertility: rationale significance, and treatment. Urol Clin North Am; 29: 817-827.
[39] Leclerc E., de Lamirande E., and Gagnon C, (1997). Regulation of protein - tyrosine phosphorylation and human sperm capacitation by reactive oxygen derivatives. Free RadicBiol Med;; 22: 643-656.
[40] Zhou X., Liu F., and Zhai S,(2007). Effect of L-carnitine and/or L-acetylcarnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr;;16(suppl 1): 383-390.
[41] Wong WY, Merkus H, Thomas CMG, Menkveld R, Zielhuis GA, et al, (2002) .“Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial.” Fertility and Sterility 77: 491-498.
[42] Ebisch I.M., Pierik F.H., De Jong F.H., Thomas C.M.G, (2006)., and Theunissen S.R.P.M.. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl;;29(2): 339-345.
[43] Jeulin C., and Lewin L.M, (1996). Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update;; 2: 87-102.
[44] Menchini-Fabris GF, Canale D, Izzo PL, et al, (1984). Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril;42:263-267.
[45] Sinclair S (2000). Male infertility: Nutritional and environmental consideration. Alt. Med. Rev. 5: 28-38.
[46] Ahmed, A,; Bello A,; Mbibu NH, Maitama, HY,; Kalayi GD, (2010). Epidemiological and aetiological factors of male infertility in northern Nigeria. Niger J Clin Pract. Jun; 13 (2): 205-9.
[47] Lenzi A, Lombardo F, Sgro` P, Salacone P, Caponecchia L, Dondero F, et al, (2003). Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril; 79:292–300.
[48] Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro, M. (2005) Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril;84:662– 671.